Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (51-60 of 308) with videos related to

Pageof 31
Sort By:
British Journal of Clinical Pharmacology|September 24, 2016
Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year periodAlfi Yasmina, Anthonius de Boer, Vera H M Deneer, et al.
Pharmacotherapy|February 10, 2006
Improving pharmacotherapy after myocardial infarction by group academic detailing using feedback data on a patient levelMenno E van der Elst, Marcel L Bouvy, Cornelis J de Blaey, et al.
Fundamental & Clinical Pharmacology|March 13, 2019
Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBaseMohammad Bakhriansyah, Ronald H B Meyboom, Patrick C Souverein, et al.
The Oncologist|June 4, 2017
<i>BRAF</i> Mutations as Predictive Biomarker for Response to Anti-EGFR Monoclonal AntibodiesEmilie M J van Brummelen, Anthonius de Boer, Jos H Beijnen, et al.
Pharmacogenomics|January 24, 2015
Economic evaluation of a pharmacogenetic dosing algorithm for coumarin anticoagulants in The NetherlandsTalitha I Verhoef, William K Redekop, Anthonius de Boer, et al.
Epidemiology (Cambridge, Mass.)|April 18, 2006
Instrumental variables: application and limitationsEdwin P Martens, Wiebe R Pestman, Anthonius de Boer, et al.
International Journal of Epidemiology|May 6, 2008
Systematic differences in treatment effect estimates between propensity score methods and logistic regressionEdwin P Martens, Wiebe R Pestman, Anthonius de Boer, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 22, 2012
The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulantsGrace Wangge, Kit C B Roes, Anthonius de Boer, et al.
Pain|August 26, 1998
Is placebo analgesia mediated by endogenous opioids? A systematic reviewGerben Ter Riet, Anton J M de Craen, Anthonius de Boer, et al.
Plos One|August 27, 2014
Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumoniaMiriam J Warnier, Frans H Rutten, Anthonius de Boer, et al.
Pageof 31

Showing results (51-60 of 308) with videos related to

Sort By:
Pageof 31
British Journal of Clinical Pharmacology|September 24, 2016
Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year periodAlfi Yasmina, Anthonius de Boer, Vera H M Deneer, et al.
Pharmacotherapy|February 10, 2006
Improving pharmacotherapy after myocardial infarction by group academic detailing using feedback data on a patient levelMenno E van der Elst, Marcel L Bouvy, Cornelis J de Blaey, et al.
Fundamental & Clinical Pharmacology|March 13, 2019
Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBaseMohammad Bakhriansyah, Ronald H B Meyboom, Patrick C Souverein, et al.
The Oncologist|June 4, 2017
<i>BRAF</i> Mutations as Predictive Biomarker for Response to Anti-EGFR Monoclonal AntibodiesEmilie M J van Brummelen, Anthonius de Boer, Jos H Beijnen, et al.
Pharmacogenomics|January 24, 2015
Economic evaluation of a pharmacogenetic dosing algorithm for coumarin anticoagulants in The NetherlandsTalitha I Verhoef, William K Redekop, Anthonius de Boer, et al.
Epidemiology (Cambridge, Mass.)|April 18, 2006
Instrumental variables: application and limitationsEdwin P Martens, Wiebe R Pestman, Anthonius de Boer, et al.
International Journal of Epidemiology|May 6, 2008
Systematic differences in treatment effect estimates between propensity score methods and logistic regressionEdwin P Martens, Wiebe R Pestman, Anthonius de Boer, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 22, 2012
The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulantsGrace Wangge, Kit C B Roes, Anthonius de Boer, et al.
Pain|August 26, 1998
Is placebo analgesia mediated by endogenous opioids? A systematic reviewGerben Ter Riet, Anton J M de Craen, Anthonius de Boer, et al.
Plos One|August 27, 2014
Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumoniaMiriam J Warnier, Frans H Rutten, Anthonius de Boer, et al.
Pageof 31